To determine the success of AIPAC it has to measured against other treatments in development for similar patient groups in MBC and the current SOC. Its not a case of what we “ perceive” to be good or bad numbers.
Results so far show wide ranging potential applications with the no side effects, which would provide significant commercial and competitive advantages to any BP company buying Immutep outright. Immutep is also the emerging leader in Lag3 technology. For all the above reasons, imo, BP will want the whole pie rather than sharing with others and there could be real competitive tension over Immutep assets.
If a BP funds our AIPAC ph3 and draws a large amount of investor interest towards Immutep, it may not suit their end game of acquisition at the lowest possible price, especially if they are planning to make a move within the next 6 -12 months, which imo would represent the best window for picking us up at a discount. A market correction could also happen within that time frame.
This is all just hypothetical musings. Unless a really compelling offer emerges we should plough on, imo, and fund our own ph3 if necessary.
- Forums
- ASX - By Stock
- IMM
- Ann: Phase II TACTI-002 trial recruitment successfully completed
Ann: Phase II TACTI-002 trial recruitment successfully completed, page-63
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 53192 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 41048 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 51196 | 0.295 |
9 | 230902 | 0.290 |
5 | 74631 | 0.285 |
22 | 480847 | 0.280 |
4 | 114783 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 41048 | 1 |
0.310 | 25000 | 2 |
0.315 | 10525 | 1 |
0.320 | 76654 | 4 |
0.325 | 30000 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online